- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- December 2023
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- November 2023
- 143 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- July 2023
- 210 Pages
Global
From €1891EUR$1,990USD£1,626GBP
- Report
- January 2024
- 150 Pages
Global
From €4608EUR$4,850USD£3,964GBP
- Report
- February 2024
- 173 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- November 2023
- 181 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- November 2023
- 199 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- February 2024
- 113 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- July 2023
- 270 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- January 2024
- 147 Pages
Global
From €4038EUR$4,250USD£3,473GBP
- Report
- December 2023
- 150 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- August 2023
- 145 Pages
Global
From €2993EUR$3,150USD£2,574GBP
- Report
- August 2023
- 268 Pages
Global
From €3420EUR$3,600USD£2,942GBP
- Report
- January 2024
- 69 Pages
Asia Pacific
From €2803EUR$2,950USD£2,411GBP
- Report
- December 2023
- 82 Pages
Europe
From €2803EUR$2,950USD£2,411GBP
- Report
- November 2023
- 209 Pages
Europe
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- October 2023
- 210 Pages
Middle East, Africa
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- October 2023
- 200 Pages
North America
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more